WMT

112.7

+1.13%↑

COST

853.99

-0.92%↓

TGT

100.39

+2.67%↑

62.82

+0.46%↑

DG.US

136.54

+2.86%↑

WMT

112.7

+1.13%↑

COST

853.99

-0.92%↓

TGT

100.39

+2.67%↑

62.82

+0.46%↑

DG.US

136.54

+2.86%↑

WMT

112.7

+1.13%↑

COST

853.99

-0.92%↓

TGT

100.39

+2.67%↑

62.82

+0.46%↑

DG.US

136.54

+2.86%↑

WMT

112.7

+1.13%↑

COST

853.99

-0.92%↓

TGT

100.39

+2.67%↑

62.82

+0.46%↑

DG.US

136.54

+2.86%↑

WMT

112.7

+1.13%↑

COST

853.99

-0.92%↓

TGT

100.39

+2.67%↑

62.82

+0.46%↑

DG.US

136.54

+2.86%↑

Home・Akciju saraksts・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Slēgts

SektorsPatēriņa aizsardzības

7.74 -5.38

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

7.38

Max

8.17

Galvenie mērījumi
By Trading Economics
Ienākumi	-7.9M -10M
Pārdošana	-5.3M 31M
Peļņas marža	-32.116
Darbinieki	406

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 9. janv.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	27M 268M
Iepriekšējā atvēršanas cena	13.12
Iepriekšējā slēgšanas cena	7.74

Ziņu noskaņojums

By Acuity

20%

80%

10 / 147 Rangs Consumer defensive

Lifecore Biomedical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 2. janv. 22:45 UTC

Galvenie tirgus virzītāji

GH Research Shares Up, Plans to Provide Update on New Drug Application

2026. g. 2. janv. 22:13 UTC

Tirgus saruna

Peļņas

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2026. g. 2. janv. 21:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Tech, Media & Telecom Roundup: Market Talk

2026. g. 2. janv. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2026. g. 2. janv. 21:07 UTC

Peļņas

Tesla Stock Pops and Drops After Fourth-Quarter Deliveries. -- Barrons.com

2026. g. 2. janv. 20:09 UTC

Tirgus saruna

Oil Futures Slip in First Trading Day of the Year -- Market Talk

2026. g. 2. janv. 19:48 UTC

Tirgus saruna

U.S. Natural Gas Futures Kick Off 2026 With A Loss -- Market Talk

2026. g. 2. janv. 18:53 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 2. janv. 18:53 UTC

Tirgus saruna

Mexico PMIs Show Manufacturing Weakness in December -- Market Talk

2026. g. 2. janv. 17:56 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Meta's Manus Acquisition May Help Fill AI Monetization Gap -- Market Talk

2026. g. 2. janv. 17:50 UTC

Tirgus saruna

Apparel Industry Seen With Strength Across Income Levels -- Market Talk

2026. g. 2. janv. 17:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2026. g. 2. janv. 16:33 UTC

Tirgus saruna

Remittances to Mexico Fell 5.7% in November -- Market Talk

2026. g. 2. janv. 16:18 UTC

Tirgus saruna

Tesla Dethroned as World's Largest EV Maker -- Market Talk

2026. g. 2. janv. 15:48 UTC

Peļņas

Software Has Been Battered by AI. Shopify, Veeva, and 3 More Stocks to Play a Turnaround. -- Barrons.com

2026. g. 2. janv. 15:17 UTC

Tirgus saruna

Tesla Expected to Make Its Switch to Robotics, AI in 2026 -- Market Talk

2026. g. 2. janv. 15:01 UTC

Tirgus saruna

Sable Seen Nearing Production Relaunch After Court Ruling -- Market Talk

2026. g. 2. janv. 15:00 UTC

Peļņas

The Maker of Biscoff Cookies Bets on a Global Expansion -- WSJ

2026. g. 2. janv. 14:56 UTC

Tirgus saruna

Tesla's Sales Drop Was Better Than Feared -- Market Talk

2026. g. 2. janv. 14:20 UTC

Tirgus saruna

Capstone Copper's Mantoverde Strike Could Be Costly -- Market Talk

2026. g. 2. janv. 14:20 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 2. janv. 14:13 UTC

Tirgus saruna

Oil Futures Open Year Lower on Oversupply Concerns -- Market Talk

2026. g. 2. janv. 13:39 UTC

Tirgus saruna

U.S. Natural Gas Futures Open Year Lower -- Market Talk

2026. g. 2. janv. 13:01 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Unicredit Could Buy Delfin's BMPS Stake, Launch Full Takeover, Equita Says -- Market Talk

2026. g. 2. janv. 12:45 UTC

Tirgus saruna

Emerging-Market Dollar Bonds Record Strong Returns in 2025 -- Market Talk

2026. g. 2. janv. 11:48 UTC

Tirgus saruna

European Gas Climbs as Cold Weather Bites -- Market Talk

2026. g. 2. janv. 11:36 UTC

Tirgus saruna

Treasury Yields, Dollar Edge Higher as Near-Term Fed Rate Cut Looks Unlikely -- Market Talk

2026. g. 2. janv. 11:30 UTC

Tirgus saruna

Copper Rally Continues, Spurred by Supply Shocks -- Market Talk

2026. g. 2. janv. 11:29 UTC

Tirgus saruna

Dollar Rises After Posting Worst Year Since 2017 -- Market Talk

2026. g. 2. janv. 11:15 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Lifecore Biomedical Inc Prognoze

Vērtējuma vienprātība

By TipRanks

Pirkt

4 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 4 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Lifecore Biomedical Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

10 / 147 Rangs Patēriņa aizsardzības

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.